High prevalence and long duration of nervous system and psychiatric adverse drug reactions in Ugandan patients taking efavirenz 600 mg daily
Author(s) -
Kay Seden,
Daniel Kiiza,
Eva Laker,
Walter Joseph Arinaitwe,
Catriona Waitt,
Mohammed Lamorde,
Saye Khoo
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky298
Subject(s) - efavirenz , medicine , adverse effect , drug , drug reaction , psychiatry , duration (music) , pediatrics , human immunodeficiency virus (hiv) , virology , antiretroviral therapy , viral load , art , literature
Efavirenz-related nervous system or psychiatric adverse drug reactions (ADRs) are conventionally reported to resolve soon after initiation, with incidence of dizziness at 8.5% in large clinical trials. Patients of black ethnicity are genetically at greater risk of elevated efavirenz exposure, which has been linked to nervous system toxicity.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom